Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. Its portfolio includes purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and other indications, as well as a Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit for monitoring human exposure to industrial pollutants and Pyrene (HOP-G) lateral flow kits for monitoring at-risk individuals without laboratory equipment. The company also offers contract SMA services and an industrial and environmental biomonitoring platform that reduces the time between sampling and results. Incorporated in 2003, Bioventix PLC is based in Farnham, United Kingdom.